Hikma Pharmaceuticals PLC, the multinational pharmaceutical company, today reports its audited results for the year ended 31 December 2024.
The Group reported revenue growth of 9% (9% in constant currency) to $3.127 billion )compared to $2.875 billion in 2023).
In 2024, Hikma continued driving…